Clin2
NCT07435103Possibly a fitNot yet recruiting

Xenon gas therapy for children with autism spectrum disorder

Autism Spectrum Disorder (ASD)Autism

Treatments studied

Part of Mental health clinical trials.

This study will test whether breathing a special gas called xenon can help reduce autism symptoms in children and teens. It's an early-stage trial that aims to see if the treatment is safe and if it may improve social and behavioral challenges.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
72 people
Ages
4 years to 18 years
Study type
Interventional

Who can take part

  • The participant must be between the ages of 4 and 18 years old.
  • A formal autism diagnosis is required, made by a specialist using standard assessment tools.
  • The Social Responsiveness Scale (SRS-2) score must be very high (T-score of 90 or above), indicating significant social challenges.
  • No brain-stimulation treatments (like TMS or transcranial electrical stimulation) in the past month before starting.
  • Any psychiatric medications must have been stopped for at least 4 weeks or 5 half-lives (whichever is longer) before the trial starts.
  • Participants should not have other major brain or nerve problems, severe physical illnesses, or genetic syndromes.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07243561Recruiting· Phase 1/Phase 2
Exosome therapy for childhood autism study

This trial tests if exosomes from stem cells can help children with autism who haven't improved enough with standard behavioral therapy. It aims to see if this treatment is safe and effective for reducing autism symptoms.

Dongfang, Hainan
NCT07257939Not yet recruiting· Phase 3
Liquid medicine for autism in children and teens

This trial tests an oral liquid medicine (called NTI164) to see if it helps reduce symptoms of autism in children and teens. It may be an option if current treatments haven't fully helped, but it requires regular study visits and certain health rules.

Brisbane, Queensland
NCT06866275Recruiting· Phase 2
Suramin for autism in boys aged 5–14

This trial tests if a medicine called suramin (KZ101) can help with social challenges in boys with autism. It's a 12-week study at one location, and families must be able to visit the site easily.

Orange, California
NCT07304440Recruiting· Phase 1
Stem cell and glutathione therapy study for children with autism

This study tests a combination of experimental treatments for children with autism spectrum disorder. It may help if your child has not had stem cell or glutathione therapy before.

Winter Park, Florida
NCT07064967Recruiting
Non-Helium MEG Brain Imaging for Autism

This study uses a special type of brain scan called magnetoencephalography (MEG) that doesn't need helium to work. They want to see if this scan can help understand brain activity in boys with autism. This research might lead to easier and cheaper ways to study the brain.

Guangzhou, Guangdong
NCT07199218Recruiting· Phase 2
Cannabis oil for autism in children aged 4 to 12

This trial tests a cannabis oil enriched with terpenes (natural compounds that may affect behavior) to see if it helps reduce severe symptoms in children with autism. It compares the oil to a placebo.

Jerusalem, N/A = Not Applicable

Hear when a new Autism trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.